default author photo

Yuemei Hu

Jiangsu Provincial Center for Disease Control and Prevention

United States

SCHOLARLY PAPERS

1

DOWNLOADS

55

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Naturally Acquired Antibodies Against Human Papillomavirus are Protective Against Subsequent Homotypic Infection: A Large-Scale Prospective Cohort Study

Number of pages: 58 Posted: 16 Feb 2021
Xiamen University, Chinese Academy of Medical Sciences - Department of Cancer Epidemiology, Peking University People's Hospital, Peking University - Department of Obstetrics and Gynecology, Jiangsu Provincial Center for Disease Control and Prevention, Peking University People's Hospital, Xiamen Innovax Biotech Company, Xiamen Innovax Biotech Company, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics, School of Public Health, Xiamen University, Nanjing University - The Affiliated Drum Tower Hospital, Shenzhen Maternity and Child Healthcare Hospital, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Chinese Academy of Medical Sciences - National Cancer Center, Peking University, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Xiamen University, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics, School of Public Health, Xiamen University, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics, School of Public Health, Xiamen University, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics, School of Public Health, Xiamen University, Xiamen University, Chinese Academy of Medical Sciences - National Cancer Center, Xiamen University - State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Xiamen University - State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Xiamen Innovax Biotech Company, Chinese Academy of Medical Sciences - National Cancer Center, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - School of Population Medicine and Public Health, Xiamen University - State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Xiamen University - State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics and Xiamen University - State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics
Downloads 55 (1,010,164)

Abstract:

Loading...